DOI: 10.1055/s-00035024

Thrombosis and Haemostasis

Issue 04 · Volume 56 · 1986 DOI: 10.1055/s-009-45127

Original Article

  • 001
    Verstraete, M; Su, C A P F; Tanswell, P; Feuerer, W; Collen, D:

    Pharmacokinetics and Effects on Fibrinolytic and Coagulation Parameters of Two Doses of Recombinant Tissue-Type Plasminogen Activator in Healthy Volunteers

  • 006
    Hutton, R A; Wickham, E A; Reed, J V; Tuddenham, E G D:

    Studies on the Action of Ethamsylate (Dicynene) on Haemostasis

  • 009
    Hemker, H C; Willems, G M; Béguin, S:

    A Computer Assisted Method to Obtain the Prothrombin Activation Velocity in Whole Plasma Independent of Thrombin Decay Processes

  • 018
    Boyer, C; Wolf, M; Vedrenne, J; Meyer, D; Larrieu, M J:

    Homozygous Variant of Antithrombin III : AT III Fontainebleau

  • 023
    Jen, C J; McIntire, L V:

    Platelet Microtubules in Clot Structure Formation and Contractile Force Generation: Investigation of a Controversy

  • 028
    Tamao, Y; Yamamoto, T; Kikumoto, R; Hara, H; Itoh, J; Hirata, T; Mineo, K; Okamoto, S:

    Effect of a Selective Thrombin Inhibitor MCI-9038 on Fibrinolysis In Vitro and In Vivo

  • 035
    Collen, D; De Cock, F; Demarsin, E; Lijnen, H R; Stump, D C:

    Absence of Synergism Between Tissue-Type Plasminogen Activator (t-PA), Single-Chain UrokinaseType Plasminogen Activator (scu-PA) and Urokinase on Clot Lysis in a Plasma Milieu In Vitro

  • 040
    Handley, D A; Tomesch, J C; Saunders, R N:

    Inhibition of PAF-lnduced Systemic Responses in the Rat, Guinea Pig, Dog and Primate by the Receptor Antagonist SRI 63-441

  • 045
    Saniabadi, A R; Lowe, G D O; Madhok, R; Spowart, K; Shaw, B; Barbenel, J C; Forbes, C D:

    A Critical Investigation into the Existence of Circulating Platelet Aggregates

  • 050
    Dietz, Brigitte; Klose, H J; Gürtler, L; Eberle, J; Deinhardt, F; Köhler-Vajta, Katalin; Peller, P:

    Correlation of Antibodies to LAV/HTLV III in Hemophiliacs with the Use of Virus-Inactivated Clotting Factors

  • 053
    Alfaro, M J; Páramo, J A; Rocha, E:

    Prophylaxis of Thromboembolic Disease and Platelet-Related Changes Following Total Hip Replacement: A Comparative Study of Aspirin and Heparin-Dihydroergotamine

  • 057
    Croset, Martine; Lagarde, M:

    In Vitro Incorporation and Metabolism of Icosapentaenoic and Docosahexaenoic Acids in Human Platelets - Effect on Aggregation

  • 063
    Åstedt, B; Hägerstrand, I; Lecander, I:

    Cellular Localisation in Placenta of Placental Type Plasminogen Activator Inhibitor

  • 066
    Hourdillé, P; Fialon, P; Belloc, F; Namur, M; Boisseau, M R; Nurden, A T:

    Megakaryocytes from the Marrow of a Patient with Glanzmann’s Thrombasthenia Lacked GPII b-III a Complexes

  • 071
    Summaria, L; Sandesara, J; Yang, G; Vagher, J P; Caprini, J A:

    In Vitro Comparison of Fibrinolytic Activity of Plasminogen Activators Using a Thrombelastographic Method: In Vivo Evaluation of the B-Chain-Streptokinase Complex in the Dog Model Using Pre-Titered Doses

  • 080
    Honey, A C; Lad, N; Tuffin, D P:

    Effect of Indomethacin and Dazoxiben on Intravascular Platelet Aggregation in the Anaesthetized Rabbit

  • 086
    Bessos, Hagop; Prowse, Christopher V:

    Immunopurification of Human Coagulation Factor IX Using Monoclonal Antibodies

  • 090
    Yamamoto, Kazuo; Kitagawa, Hisayo; Tanoue, Kenjiro; Tsuruo, Takashi; Yamamoto, Naomasa; Yamazaki, Hiroh:

    Role of Heparin in Tumor Cell-Induced Platelet Aggregation

  • 095
    Fitzsimmons, C M; Cawston, T E; Barnes, M J:

    The Platelet Reactivity of Collagen Type I: Evidence for Multiple Platelet-Reactive Sites in the Type I Collagen Molecule

  • 100
    Liu, C Y; Sobel, Joan H; Weitz, J I; Kaplan, Karen L; Nossel, H L:

    Immunologic Identification of the Cleavage Products from the Aα- and Bβ-Chains in the Early Stages of Plasmin Digestion of Fibrinogen

    • Letter to the Editor

  • 107
    Kluft, C; Jie, A F H; Lowe, G D O; Blamey, S L; Forbes, C D:

    Association Between Postoperative Hyper-Response in t-PA Inhibition and Deep Vein Thrombosis

  • 108
    Miyashita, C; Köhler, M; Hellstern, P; Wenzel, E:

    Urokinase Preparations: Quality Control and Stability in Solution

  • 109
    Rodemer, B; Hellstern, P; Wetzler, E; Wenzel, E:

    Plasma Heparin-Like Activities After Percutaneous Application of a Low Molecular Weight Heparin in Healthy Subjects

  • 110
    de Gaetano, G; Concetta Gambino, Maria; Cerletti, Chiara:

    Differential Effects of Oral Low-Dose Aspirin on Prostacyclin Synthesis by Saphenous or Mesenteric Venous Tissues

  • 111
    Takahashi, H; Tatewaki, W; Nagayama, R; Hanano, M; Wada, K; Shibata, A:

    Acquired and Congenital von Willebrand Factor Abnormalities Congenital Cardiac Defects